Group 1 - The core point of the article is that 开拓药业 (stock code: 9939) announced a financing plan through the placement of existing shares and subscription for new shares, raising approximately HKD 40.34 million [1] - The financing involves the placement of 20,673,000 shares at a price of HKD 2.08 per share, which represents a discount of about 18.8% compared to the last closing price of HKD 2.56 [1] - The shares being placed account for approximately 4.6% of the existing issued share capital and will represent about 4.4% of the enlarged share capital after completion [1] Group 2 - The funds raised will be used for general working capital and business operations of the company [1] - The financing is conducted under a general mandate granted by the shareholders' meeting and is expected to be completed within 14 days from the agreement date or at another time agreed upon by the company, seller, and placement agent [1]